Mobia Medical IPO Priced at $15, Aims for $150 Million

IPO Launch Details

Mobia Medical Inc. announced the pricing of its initial public offering of 10 million common shares at $15.00 per share. The company anticipates raising gross proceeds of approximately $150 million before deducting underwriting discounts and offering expenses.

The stock is scheduled to begin trading on the Nasdaq Global Select Market on May 8, 2026, under the ticker symbol MOBI.

Company and Offering Overview

Based in Austin, Texas, Mobia Medical develops medical devices for stroke recovery, including its FDA-approved Vivistim Paired VNS System. The offering is being managed by lead bookrunners BofA Securities, J.P. Morgan, and Goldman Sachs & Co. LLC.

Underwriters have a 30-day option to purchase up to an additional 1.5 million shares at the IPO price.

Market Implications

This public offering marks a significant capital infusion for the med-tech firm, funding further development and commercialization of its stroke recovery technologies. The IPO's success will be a key indicator of investor appetite for specialized medical device companies.

The offering is expected to close on May 11, 2026, subject to customary closing conditions.

Concluding Outlook

Market participants will closely monitor MOBI's trading debut to gauge its post-IPO performance. The capital raised is expected to strengthen the company's position in the neurological device market and support its long-term growth strategy.

FAQ

Q: What is Mobia Medical's IPO price?
A: The IPO is priced at $15.00 per share.

Q: How much does Mobia Medical aim to raise?
A: The company expects to raise gross proceeds of approximately $150 million.

Q: Where will Mobia Medical's stock trade?
A: The stock will trade on the Nasdaq Global Select Market under the ticker symbol "MOBI".

Source: Investing.com